Rg3039
CAS: 1005504-62-0
Ref. TM-T3336
| 2mg | 38.00 € | ||
| 5mg | 55.00 € | ||
| 10mg | 91.00 € | ||
| 25mg | 159.00 € | ||
| 50mg | 253.00 € | ||
| 100mg | 407.00 € | ||
| 500mg | 915.00 € | ||
| 1ml*10 (DMSO) | 62.00 € |
Estimated delivery in United States, on Thursday 16 May 2024
Product Information
Name:
Rg3039
Synonyms:
- PF-06687859
CAS:
Description:
Rg3039 (PF-06687859) is a potent DcpS inhibitor. DcpS is a therapeutic target for spinal muscular atrophy. Spinal muscular atrophy (SMA) is caused by deletion or mutation of both copies of the SMN1 gene which produces an essential protein known as SMN. RG3039 improves motor function in SMA mice. RG3039 also showed activity to improve survival, function and motor unit pathologies in two SMA mouse models.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
432.35
Formula:
C21H23Cl2N5O
Purity:
99.58%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T3336 Rg3039
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
